apteka.lviDrugs24.com

Monthly offers  -Prices-Offer price Monthly offers 
Latvian pharmacies maps Duty doctors. medicaid
Medicines and generics searching-PricesDrugs search by alphabet
Vaccination offers. Pricelists-Prices-Offer price Vaccination offers
Space Weather Space weather
    
Queues for medical examinationsLists of compensated medicines        E‑health         
 LV 

AFRIN NASAL SPRAY 0.5MG/ML 15ML

Attention: Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for treating a health problem or disease, or prescribing any medication. iDrugs24.com is not responsible for any damage to your health as the result of self treatment.

# On 2024-Mar-28
AFRIN-DEGUNA-drug/medicine -spray-aerosolaproximate price on "AFRIN NASAL SPRAY 0.5MG/ML 15ML" in Riga city, Latvia is:
  • 4.82€  5.21$  4.13£  557Rub  55.5SEK  21PLN  19.08₪ 

AFRIN NASAL SPRAY 0.5MG/ML 15ML


Maximum allowed state defined price ( from ZVA webpage) Euro:State defined maximum allowed price indicated on the picture on drug/medicine -spray-aerosol AFRIN NASAL SPRAY 0.5MG/ML 15ML     Recheck

ATC codeR01AA05 

Active substances: Oxymetazolinum

 


Vendor, principal: Schering-Plough Europe
No prescription needed/Patient care products, dressings, gloves, medical devices,...

* This table was compiled fully automatically, independently from any advertisers, transparently and without any modification relaying the open offers available on the mentioned dates.
AFRIN 0.5 mg/ml nosies purškalas (tirpalas) 15 ml

 .

AFRIN MENTHOL 0.5MG/1ML 15ML

Package leaflet:Information for the user

Afrin, 0,5 mg/ml nasal spray solution Afrin Menthol, 0,5 mg/ml nasal spray solution

Oxymetazoline hydrochloride

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.
-   Keep this leaflet. You may need to read it again.
-   Ask your pharmacist if you need more information or advice.
-   If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
-   You must talk to a doctor if you do not feel better of ir you feel worse after 7 days.

What is in this leaflet

1.   What Afrin is and what it is used for
2.   What you need to know before you use Afrin
3.   How to use Afrin
4.   Possible side effects
5.   How to store Afrin
6.   Content of the pack and other information

1. What Afrin is and what it is used for

The full name of your medicine is:
Afrin 0.5mg/ml Nasal Spray Solution Afrin 0.5mg/ml Nasal Spray Solution Menthol

What Afrin is

Afrin nasal spray solution contains the active substance oxymetazoline hydrochloride.

How Afrin works

Afrin is a decongestant, which relieves a blocked nose by constricting the blood vessels in the nose. It acts within a few minutes and lasts for hours.

When Afrin should be taken

Afrin is used for the symptomatic relief of nasal congestion due to hay fever, common cold and sinusitis. It can be taken every 12 hours.
You must talk to a doctor if you do not feel better or if you feel worse after 7 days.

2. What you need to know before you use Afrin Do not use Afrin

•   if you are allergic to oxymetazoline hydrochloride or any of the other ingredients of this medicine (listed in section 6)
•   if you are taking monoamine oxidase inhibitors (MAO inhibitors, used in the treatment of Parkinson’s disease and depression). MAO inhibitors may increase the hypertensive effects of oxymetazoline
•   if you have narrow angle glaucoma (increased eye pressure)
•   if you have had trans-sphenoidal hypophysectomy (surgical removal of the pituitary gland)
•   if you have inflammation of the skin and mucosa of the nasal vestibule and encrustation (rhinitis sicca)
•   if you have acute coronary disease or cardiac asthma

Warnings and precautions

Talk to your doctor if you have:
-   coronary artery disease
-   hypertension (high blood pressure)
-   hyperthyroidism (overactive thyroid gland)
-   diabetes mellitus
-   difficulty in urination due to enlargement of the prostate gland
If used over a longer period Afrin may cause a blocked nose. It is not recommended to use for longer than one week. Contact your doctor if symptoms worsen or do not improve after 7 days.

Children

Do not use Afrin in children under 6 years of age (See Section 3 How to use Afrin)

Other medicines and Afrin

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.This includes medicines obtained without a prescription.
The hypertensive effects of oxymetazoline may increase when used together with:
•   some types of antidepressants: tricyclic antidepressants, maprotiline, monoamine oxidase inhibitors (MAO inhibitors)

Pregnancy and breast-feeding Pregnancy

Oxymetazoline has not been associated with adverse pregnancy outcome. Afrin can be used in pregnant women if used as recommended. Caution should be exercised in patients with hypertension or signs of reduced placental perfusion. Frequent or prolonged use of high doses may reduce placental perfusion.
Breast Feeding
It is not known if oxymetazoline is excreted into breast milk. In view of the lack of data on the use of oxymetazoline during lactation, Afrin should not be used during breast feeding.

Driving and using machines

No effect on ability to drive or use of machines has been observed.

Afrin contains benzalkonium chloride; Afrin Nasal Spray Menthol contain propylene glycol.

•   Benzalkonium chloride (a preservative) is an irritant and may cause skin reactions.
•   Propylene glycol may cause skin irritation

3. How to use Afrin

Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Dosage
Adults and children > 10 years; 1-2 sprays in each nostril, every 12 hours.
Children 6-10 years 1 spray in each nostril, every 12 hours.
Not more than a total of 8 sprays for adults (4 for children) should be given in any 24 hours.
Do not exceed the stated dose.
Afrin should not be used for longer than 7 days unless prescribed by your doctor. An interval of several days should elapse before re-administration of the product.
Administration
Shake well before use. Before first use, prime the unit by depressing the pump several times until the first full spray is achieved.
Whilst holding upright the spray nozzle should be inserted into each nostril in turn and squeezed firmly one or two times whilst breathing in.
After use wipe nozzle clean. Use of this product by more than one person may spread infection.

If you use more Afrin than you should

If you use more Afrin than you should, you should contact your doctor or go to a hospital immediately and take the bottle with you.

If you forget to use Afrin

Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4.   Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Possible side effects are:
Uncommon (occurring in less than 1 in 100 people), sneezing, dryness or irritation in the nose, mouth or throat andblocked nose.
Rare (occurring in less than 1 in 1000 people), anxiety, fatigue, irritability, disturbed sleep in children, rapid heart beat, palpitations, raised blood pressure, , swelling of the nasal lining, headache, nausea, flushing, rash and visual disturbances.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in this leaflet. You can also report side effects directly via www.ravimiamet.ee. By reporting side effects you can help provide more information on the safety of this medicine.

5.   How to store Afrin

•   Keep this medicine out of the sight and reach of children.
•   Store below 25°C. Do not refrigerate or freeze.
•   Do not use this medecine after the expiry date which is stated on the bottle after Exp: The expiry date refers to the last day of that month.
•   Use within 30 days of first opening.
•   Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6.   Contents of the pack and other information What Afrin contains

Afrin

-   The active substance is oxymetazoline HCl 0.5 mg/ml
-   The other ingredients are disodium edetate, disodium phosphate anhydrous, sodium phosphate monobasic monohydrate, povidone K29-32, benzalkonium chloride, PEG 1450, purified water, benzyl alcohol, microcrystalline cellulose and carmellose sodium, lemon flavour, including natural and artificial flavours, alcohol and DL-alpha tocopherol.

Afrin Menthol

-   The active substance is oxymetazoline HCl 0.5 mg/ml
-   The other ingredients are disodium edetate, disodium phosphate anhydrous, sodium phosphate monobasic monohydrate, povidone K29-32, benzalkonium chloride, PEG 1450, propylene glycol, purified water, benzyl alcohol, microcrystalline cellulose and carmellose sodium, cineole, camphor, levomenthol.

What Afrin looks like and contents of the pack

Afrin is a white to off white gel like solution in a white light-resistant 15 ml high density plastic bottle with a white plastic pump.

Marketing Authorisation Holder and Manufacturer

Marketing Authorization Holder:
UAB Bayer Sporto 18 LT-09238 Vilnius Lithuania
Manufacturer:
Berlimed S.A.,
C/Francisco Alonso no.7
Poligono Industrial Santa Rosa Alcala de Henares
28806 Madrid
Spain
For any information about this medicine, please contact the local representative of the Marketing
Authorisation Holder
Bayer OÜ
Löötsa 2
11415 Tallinn
Phone: +372 655 8565

This medicinal product is authorized in the Member States of the EEA under the following names:

AFRIN: Czech Republic, Estonia, Latvia, Lithuania, The Netherlands, Slovakia, Slovenia, Spain, Rumenia
AFRIN Comfort: Hungary AFRIN ND: Bulgaria, Poland NASAROX: Portugal Rhinacept: Greece

This leaflet was last revised in April 2018.






  Instruction, annotation source for medicine: State Agency of Medicines, Estonia





• Medicaments images are for illustrative purposes only and may differ from the actual product.


[*1]

DDD. Information source: WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health


Back


Facebook Tweeter E-mail link
For pharmacies & healthstores For advertisers About

Copyright © 2011-2024 iDrugs24.com. All rights reserved